BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31858551)

  • 41. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-509-5p suppresses the proliferation, migration, and invasion of non-small cell lung cancer by targeting YWHAG.
    Wang P; Deng Y; Fu X
    Biochem Biophys Res Commun; 2017 Jan; 482(4):935-941. PubMed ID: 27894843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
    Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
    Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1.
    Wang R; Ma Y; Yu D; Zhao J; Ma P
    Biomed Pharmacother; 2015 Mar; 70():64-71. PubMed ID: 25776481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells.
    Yang YR; Li YX; Gao XY; Zhao SS; Zang SZ; Zhang ZQ
    Int J Clin Exp Pathol; 2015; 8(9):10847-53. PubMed ID: 26617798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA.
    Du M; Zhang Y; Mao Y; Mou J; Zhao J; Xue Q; Wang D; Huang J; Gao S; Gao Y
    Biochem Biophys Res Commun; 2017 Jan; 482(4):582-589. PubMed ID: 27856248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
    Xu S; Ge J; Zhang Z; Zhou W
    Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
    Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
    Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
    Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
    Xia LH; Yan QH; Sun QD; Gao YP
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression.
    Zheng J; Zhang Y; Cai S; Dong L; Hu X; Chen MB; Zhu YH
    Cancer Lett; 2020 Apr; 476():129-139. PubMed ID: 32081805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-140's inhibition on the cell migration and invasion of non-small cell lung cancer by down-regulating Smad3 expression.
    Han P; Wang XH; Han YF; Chen GM
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9471-9479. PubMed ID: 31773685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long noncoding RNA HOXA-AS2 promotes cell migration and invasion via upregulating IGF-2 in non-small cell lung cancer as an oncogene.
    Zheng FX; Wang XQ; Zheng WX; Zhao J
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4793-4799. PubMed ID: 31210310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
    Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
    BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
    Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
    Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-875 can regulate the proliferation and apoptosis of non-small cell lung cancer cells via targeting SOCS2.
    Tong JL; Wang LL; Ling XF; Wang MX; Cao W; Liu YY
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5235-5241. PubMed ID: 31298374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.